Ask AI
ProCE Banner Activity

Cancer Cachexia: A Clinical Unmet Need in Oncology Practice

Clinical Thought

Read this commentary for an expert’s thoughts on what you should know about the management of patients with cancer and cachexia, including the underlying biology of the condition, symptoms, diagnosis, and assessment; current multispecialty management recommendations; and future directions in treatment.

Released: April 02, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Pfizer Inc.

Pfizer, Inc.

Target Audience

This activity is intended for medical oncologists, oncology nurses and nurse practitioners, physician assistants, pharmacists and other healthcare professionals involved in the care and treatment of people with cancer.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify the signs and symptoms of cachexia in patients with cancer to foster early recognition and timely treatment of the condition

  • Apply appropriate diagnostic tools to assess, measure, and accurately code cachexia in clinical practice

  • Employ evidence-based clinical strategies to foster the optimal management of cachexia in patients with cancer, taking into consideration the latest clinical data

  • Discuss current and emerging therapeutic options for the treatment of cancer cachexia, including their mechanisms of action and potential patient recruitment opportunities for clinical trials

Disclosure

Primary Author

Jann Arends, MD: consultant/advisor/speaker: Danone, Fresenius Kabi, Nestle, Pfizer.